Hello Fellow ChartWatchers! | Welcome to December! It's the most wonderful time of the year, and what better way to kick off the last month of 2018 than with a fresh new ChartWatchers Newsletter! Now, I know you might be wondering, "Why is Grayson so excited about December? Doesn't he know it's cold and dark and I have way too much to do before the holidays??" Well, it's not just the eggnog and gingerbread cookies that's got me going. 'Tis the season of savings, my friends, and we're celebrating here at StockCharts with a Holiday Special! For a limited time only this month, we're giving you 2 free months of StockCharts service when you sign up or renew for a 12-month subscription. That means you can save up to $80 off our regular subscription prices. If you're a current StockCharts Member and love the service, you can extend your existing subscription now and save. Or, if you're not a member but have been thinking about signing up, this is the best time of year to do so. Click Here to take advantage of our Holiday Special today and get your 2 free months of StockCharts. | Happy charting, | | |
THIS WEEK'S ARTICLES | The Market Message | Short-Term Trend is Improving | by John Murphy | Editor's Note: This article was originally published in John Murphy's Market Message on Friday, November 30th at 2:36pm ET. There are lots of way to determine the trend of the stock market. The placement of moving average lines is one of them. Bollinger bands (invented by John Bollinger)... | | | | | Art's Charts | Confirming Moving Average Signals in the S&P 500 | by Arthur Hill | The S&P 500 is the most widely used benchmark for U.S. stocks and the 200-day SMA is the most widely used moving average. Together, chartists can use the S&P 500 and the 200-day SMA to determine the broad trend for the stock market. The S&P 500, however, does not tell the entire story. Note that the top 50 stocks (10% of the total) account for 50% of the index weightings. Chartists... | | | | | | The Canadian Technician | Multiple Big Name Pharma Stocks Help Remedy The Pain | by Greg Schnell | Pharmaceutical stocks were a standout in November. The big global names had an exceptional month. While they are categorized as defensive stocks, these heavyweights have very powerful biotechnology investments. The pharmaceutical stocks listed below all hit new highs within November. While the $SPX was up about 2% for the month, all of lifting to get positive for the month happened over... | | | | | Trading Places | Combining Strong Technicals And Fundamentals To Wildly Outperform The S&P 500 | by Tom Bowley | Everybody wants the secret formula. You know, the one where you never lose money. Well, I haven't found THAT one yet, but trading companies that have recently beaten Wall Street revenue and EPS estimates is a fairly solid runner-up strategy. A company that produces results in excess of analysts' expectations often has a management team trusted by Wall Street. Before I... | | | | | Earnings Beats | Sticking With Companies That Report Strong Earnings | by John Hopkins | The market finally found its legs last week after the Fed signaled they might slow down their interest rate-raising campaign. In fact, after being technically wounded for some time, all of the major indexes closed back above their respective 20-day moving averages, with the Dow clearing its 200 day as well. The move higher was most welcomed by the bulls, who have been behind the eight ball... | | | | | | The Traders Journal | Ask Yourself This Question, But Make Sure You Do It This Sunday | by Grayson Roze | I’m going to let you in on a little secret. The bulk of my financial analysis, portfolio reviews, and trading decision making happens on Sundays. Sure, I have daily trading routines that are tremendously important, and of course, I'm constantly watching the market during the week. But the routines that I believe are most crucial to my investing process, those are reserved for Sunday morning and... | | | | | DecisionPoint | Healthcare Sector Bullish in All Three Timeframes | by Erin Swenlin | In my Thursday article in the DecisionPoint blog, I discussed the new PMO BUY signals on the DP Scoreboards and finished off the article with a chart of the Healthcare Sector ETF (XLV) after I received a new Intermediate-Term Trend Model BUY signal (a positive 20/50-EMA crossover on the daily chart). I decided to research further because today the daily chart of XLV looked particularly bullish... | | | | | RRG Charts | Plotting Breadth Indicators On Relative Rotation Graphs - Part II | by Julius de Kempenaer | After finishing the previous article on plotting breadth indicators on Relative Rotation Graphs I have spent hours and hours on studying probably a couple of thousand different RRGs holding various groups of sectors in combination with their breadth equivalents. And although I did not find the perfect prediction tool or the ideal leading indicator I do think using these alternative... | | | | | MORE ARTICLES → | |
No comments:
Post a Comment